Expand GALT Menu
GALT MENU

GALT Latest Press Releases

-- January 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT PRNewswire 10:00 AM

-- January 15, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT PRNewswire 10:00 AM

-- January 13, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT Globe Newswire 4:28 PM

-- January 8, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT PRNewswire 10:00 AM

-- January 7, 2026 --

GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 10:40 AM

-- January 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT Globe Newswire 1:15 PM

-- January 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT PRNewswire 10:00 AM

-- December 30, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT Globe Newswire 12:39 PM

-- December 29, 2025 --

GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with The Schall Law Firm Business Wire 9:54 PM

-- December 19, 2025 --

Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027 Globe Newswire 8:00 AM

-- November 14, 2025 --

Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update Globe Newswire 8:00 AM

-- November 10, 2025 --

Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting Globe Newswire 8:00 AM

-- October 20, 2025 --

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference Globe Newswire 8:00 AM

-- October 7, 2025 --

Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025 Globe Newswire 8:00 AM

-- September 2, 2025 --

Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes